Treating the Symptoms of Eczema with Cannabis Topical


Ongoing research points to cannabis being a very effective treatment for chronic skin conditions.
May 29, 2017
Health


What Is Eczema

Eczema is not one specific condition, but rather a collective term for a group of related skin disorders that cause symptoms like inflammation, redness, dryness and scaling. A diagnoses of eczema can be used to describe any type of dermatitis or “itchy rash.” Eczema is an itchy, red rash that can appear all over the body. It occurs among people who have very dry, sensitive skin. The skin can blister and crack in some cases. People with eczema are usually diagnosed with it when they are babies or young children.

Eczema symptoms
  • Dry, sensitive skin
  • Intense itching
  • Red, inflamed skin
  • Recurring rash
  • Scaly areas
  • Rough, leathery patches
  • Oozing or crusting
  • Areas of swelling
  • Dark colored patches of skin

Cannabis has been historically used to treat a lot of ailments including eczema. In eczema, most patients use marijuana by topical application. When applied topically, compounds in the herb bind to cell receptors in the skin’s immune cells. Applying MCDSA topical cannabis creams to the agitated area reduces the inflammatory response. This cuts down on the irritation and allows your skin to heal and return to normal. Cannabis cream cannot make you high.

Recommended treatment for Eczema

We recommend using a topical:

  • Tropical: Apply 2-3 x daily a light coating to effected areas, allow to air dry before covering.

Topicals are 1000mg of THC cannabinoid extract base combine with essential oils, in a 30ml ointment jar.

Please feel free to contact us with your questions below or visit our Product Guide for more information on the most-trusted, healthiest and highest-quality products on the market.

Disclaimer
All information on this page is subject to MCDSA’s disclaimer.



CONTACT US

Start your medical cannabis journey now. How can we help?


Added to cart

You have no products in your cart!

2024 © MCDSA